Page last updated: 2024-08-05 11:43:06

nitrate ester

Any member of the class of nitrates resulting from the esterification of nitric acid with an alcohol.

ChEBI ID: 51080

Members (9)

MemberDefinitionRole
erythrityl tetranitrateErythritol in which each of the hydroxy groups has been converted to the corresponding nitrate ester. It is a vasodilator with properties similar to nitroglycerin. It is usually used diluted with lactose or other suitable inert excipients, in order to minimise the risk of explosion; undiluted erythrityl tetranitrate can be exploded by percussion or excessive heat.erythrityl tetranitrate
isosorbide dinitrateisosorbide dinitrate
isosorbide-5-mononitrateisosorbide mononitrate
naproxen-n-butyl nitrateA carboxylic ester obtained by formal condensation of the carboxy group of naproxen with the hydroxy group of 4-(nitrooxy)butanol. A cyclooxygenase-inhibiting nitric oxide donator that is metabolised to naproxen and a nitric oxide donating moiety, effective in treatment of osteoarthritis.naproxcinod
nicorandilA pyrimidinecarboxamide that is nicotinamide in which one of the hydrogens attached to the carboxamide nitrogen is replaced by a 2-(nitrooxy)ethyl group. It has both nitrate-like and ATP-sensitive potassium channel activator properties, and is used for the prevention and treatment of angina pectoris.nicorandil
nitroflurbiprofenA carboxylic ester obtained by formal condensation of the carboxy group of flurbiprofen with the free hydroxy group of 4-(nitrooxy)butanol. It is a non-steroidal anti-inflammatory agent showing inhibitory effects against the cyclooxygenases COX1 and COX2.nitroflurbiprofen
pentrinitrolpentrinitrol
propatyl nitratepropatylnitrate
trolnitratetrolnitrate

Research

Studies (4,943)

TimeframeStudies, Drugs in This Class (%)All Drugs %
pre-19901,708 (34.55)18.7374
1990's1,308 (26.46)18.2507
2000's1,114 (22.54)29.6817
2010's649 (13.13)24.3611
2020's164 (3.32)2.80

Study Types

Publication TypeStudies, Drugs in This Class (%)All Drugs (%)
Trials1,688 (27.24%)5.53%
Reviews493 (7.96%)6.00%
Case Studies372 (6.00%)4.05%
Observational13 (0.21%)0.25%
Other3,631 (58.59%)84.16%